Practical radiation oncology
IF
2.95
Papers
1270
Papers 1384
1 page of 139 pages (1,384 results)
Newest
#1Robert J. Amdur (UF: University of Florida)H-Index: 63
#2James B. Yu (Yale University)H-Index: 61
Source
#1Serenna G. Gerhard (London Health Sciences Centre)
#2David A. Palma (London Health Sciences Centre)H-Index: 55
Last. Mark T. Corkum (U of T: University of Toronto)H-Index: 5
view all 0 authors...
Abstract null null Purpose null Organ at risk (OAR) dose constraints are a critical aspect of SABR treatment planning. There is limited evidence supporting preferred dose constraints for many OARs. We sought to evaluate OAR dose constraints used in ongoing clinical trials of SABR for oligometastatic disease. null null null Methods and Materials null Clinicaltrials.gov was searched from inception to February 2020 to capture actively accruing clinical trials using SABR in oligometastatic disease. ...
Source
#1Alexandra N. De Leo (UF: University of Florida)H-Index: 2
#2William M. Mendenhall (UF: University of Florida)H-Index: 109
Last. Robert J. Amdur (UF: University of Florida)H-Index: 63
view all 0 authors...
ABSTRACT null null Purpose/Objectives null There is controversy about the need to target the mucosa of the larynx and hypopharynx during radiotherapy (RT) for squamous cell carcinoma of an unknown primary site (SCCA-UP). By 1997, the policy in our department was to target only the oropharynx and nasopharynx in patients with SCCA-UP metastatic to the level II cervical nodes. The purpose of this study was to report the rate of cancer recurrence in the larynx or hypopharynx using an approach that e...
Source
#1Brett A. Morris (UW: University of Wisconsin-Madison)H-Index: 4
#2Adam R. Burr (UW: University of Wisconsin-Madison)H-Index: 10
Last. Steven P. Howard (UW: University of Wisconsin-Madison)H-Index: 16
view all 0 authors...
Source
#1James H. Laird (Yale University)
#2Jonathan S. Leventhal (Yale University)H-Index: 11
Last. Shari Damast (Yale University)H-Index: 14
view all 0 authors...
Abstract null null Using the Morbidity and Mortality format, we describe a case of radiation recall dermatitis in a patient treated with adjuvant radiation therapy followed by capecitabine for triple negative breast cancer with residual disease after neoadjuvant chemotherapy.
Source
#1James Janopaul-Naylor (Emory University)H-Index: 3
#2David C. Qian (Emory University)H-Index: 2
Last. Jeffrey D. Bradley (Emory University)H-Index: 9
view all 0 authors...
The COVID-19 pandemic altered the workplace for medical education. As restrictions ease, the opportunities provided by virtual rotations remain. Radiation Oncology rotations based around virtual participation with patients (consults, follow-ups, and brachytherapy), contouring and reviewing external beam plans, didactics, and unstructured office hours have been well-received at multiple institutions. Virtual rotations decrease barriers to access including lack of a Radiation Oncology Department a...
Source
#1Bo Qiu (SYSU: Sun Yat-sen University)H-Index: 9
#2Mai Xiong (SYSU: Sun Yat-sen University)
Last. Maosheng LinH-Index: 2
view all 0 authors...
Abstract null null Purpose null We aimed to explore the efficacy and toxicity of split-course hypofractionated radiotherapy with concurrent chemotherapy (HRT-CHT) in patients with locally advanced non-small cell lung cancer (LANSCLC) in this single-arm, phase II study. null null null Methods null LANSCLC patients were considered eligible if their forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC%) and carbon monoxide diffusing capacity (DLCO%) were ≥40% and ≥45%, respectively....
Source
#1Claire Meynard (University of Paris)H-Index: 1
#2Audrey Mansuet-Lupo (University of Paris)H-Index: 16
Last. P. Giraud (University of Paris)H-Index: 4
view all 0 authors...
Abstract null null Purpose null Radiation therapy for locally advanced non-small cell lung cancer (NSCLC) should treat the whole tumor, including its microscopic extensions, while protecting adjacent organs at risk as much as possible. The aim of our study is to evaluate the size of microscopic tumor extension (MEmax) in NSCLC, and search for potential predictive factors. null null null Methods and Materials null We retrospectively selected 70 patients treated with post-operative radiation thera...
Source
#1Adam A. Garsa (SC: University of Southern California)H-Index: 13
#2Julie K. Jang (SC: University of Southern California)H-Index: 1
Last. Susanne Hempel (AN: RAND Corporation)H-Index: 41
view all 0 authors...
Abstract null Purpose null This evidence report synthesizes the available evidence on radiation therapy for brain metastases. null Methods and Materials null The literature search included PubMed, EMBASE, Web of Science, Scopus, CINAHL, clinicaltrials.gov, and published guidelines in July 2020; independently submitted data, expert consultation, and contacting authors. Included studies were randomized controlled trials (RCTs) and large observational studies (for safety assessments), evaluating wh...
1 CitationsSource
#1Jacob Hogan (WashU: Washington University in St. Louis)
#2Amit Roy (WashU: Washington University in St. Louis)H-Index: 5
Last. B.C. Baumann (Leonard Davis Institute of Health Economics)H-Index: 3
view all 6 authors...
BACKGROUND AND PURPOSE There is evidence of practice consolidation in US healthcare in recent years. To our knowledge, a detailed quantitative study of recent changes in radiation oncology practice size has not been performed. We aim to evaluate radiation oncology practice size changes between 2012 and 2020 in the US. MATERIALS AND METHODS Using the Medicare Physician Compare Database, we identified practices employing radiation oncologists using their Taxpayer Identification Number and individu...
Source
12345678910
Top fields of study
Radiology
Surgery
Nuclear medicine
Radiation therapy
Medicine